United States: Supreme Court Denies Cert. In Skinny Label Case, But The Impacts From GSK v. Teva Continue - Axinn Veltrop & Harkrider

Today, the Supreme Court denied certiorari in Teva Pharms. USA, Inc. v. GlaxoSmithKline, LLC, 22-37, locking in the Federal Circuit's second panel decision, which held that Teva's attempted section viii carveout of an indication ...